专家建议

新型冠状病毒肺炎疫情下甲状腺功能亢进症和甲状腺功能减退症管理专家建议

展开
  • 国家代谢性疾病临床医学研究中心(上海)

收稿日期: 2022-05-26

  网络出版日期: 2022-04-25

Expert suggestions on the management of hyperthyroidism and hypothyroidism in the time of COVID-19

Expand
  • National Metabolic Diseases Clinical Research Center (Shanghai)

Received date: 2022-05-26

  Online published: 2022-04-25

摘要

甲状腺功能亢进症和甲状腺功能减退症患者通常需要在门诊长期治疗,甲状腺功能检测等实验室检查是患者病情管理中非常重要的参考依据。在新型冠状病毒(新冠)肺炎疫情期间,为配合疫情管控措施,部分患者无法及时至门诊复诊。本文为疫情特殊时期甲状腺功能异常患者的处理提供专家建议。

本文引用格式

中华医学会内分泌学分会 . 新型冠状病毒肺炎疫情下甲状腺功能亢进症和甲状腺功能减退症管理专家建议[J]. 诊断学理论与实践, 2022 , 21(02) : 128 -129 . DOI: 10.16150/j.1671-2870.2022.02.003

Abstract

Hyper- and hypo-thyroidism are chronic conditions that are usually treated in the outpatient clinic. Laboratory tests such as thyroid function tests are very important reference for patients′ disease management. In the time of coronavirus disease 2019(COVID-19), in order to cooperate with the epidemic control measures, some patients could not go to the outpatient clinic in time. This article provides expert suggestions for the management of thyroid dysfunction during the special period of the epidemic.

参考文献

[1] Lisco G, De Tullio A, Jirillo E, et al. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects[J]. J Endocrinol Invest, 2021, 44(9):1801-1814.
[2] Boelaert K, Visser WE, Taylor PN, et al. Endocrinloogy in the time of COVID-19: Management of hyperthyroidism and hypothyroidism[J]. Eur J Endocrinol, 2020, 183(1):G33-G39.
[3] Burch HB, Cooper DS. Anniversary review: Antithyroid drug therapy: 70 years later[J]. Eur J Endocrinol, 2018, 179(5):R261-R274.
[4] Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis[J]. Thyroid, 2016, 26(10):1343-1421.
[5] Chaker L, Bianco AC, Jonklaas J, et al. Hypothyroidism[J]. Lancet, 2017, 390(10101):1550-1562.
文章导航

/